{"id":"https://openalex.org/W4298029361","doi":null,"title":"Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.","display_name":"Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W4298029361","pmid":"https://pubmed.ncbi.nlm.nih.gov/16764097"},"language":"en","primary_location":{"id":"pmid:16764097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16764097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prescrire international","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W4298029361"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1755,"has_fulltext":false,"cited_by_count":5,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.56104942,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"15","issue":"83","first_page":"94","last_page":"97"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8610000014305115},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7620000243186951},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.7570000290870667},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.699999988079071},{"id":"https://openalex.org/keywords/folfox4","display_name":"FOLFOX4","score":0.7369999885559082},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8100000023841858},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.35600000619888306},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.699999988079071},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.5419999957084656},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2779804826","wikidata":"https://www.wikidata.org/wiki/Q45435667","display_name":"Folinic acid","level":4,"score":0.9830672740936279},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.9359291791915894},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8799407482147217},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.8144105672836304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7737079858779907},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.6080114245414734},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5735135078430176},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5102274417877197},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.49814701080322266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46635308861732483},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.423380047082901},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3622991442680359},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31821489334106445},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08175310492515564},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013534","descriptor_name":"Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:16764097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16764097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prescrire international","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2067139950","https://openalex.org/W2112759697","https://openalex.org/W2157769714","https://openalex.org/W2168269586","https://openalex.org/W2043340155","https://openalex.org/W2156575195","https://openalex.org/W2316441588","https://openalex.org/W2092215947","https://openalex.org/W2098872652","https://openalex.org/W1977996693"],"abstract_inverted_index":{"(1)":[0],"The":[1,9,91],"prognosis":[2],"for":[3,72,278,331],"metastatic":[4,76,335],"colorectal":[5,77,336],"cancer":[6],"is":[7,51,68,152,162,246,318,323],"grim.":[8],"best":[10],"treatment":[11,74,333],"results":[12,138],"are":[13,139],"obtained":[14],"by":[15],"adding":[16,250],"irinotecan":[17],"to":[18,28,45,141,143,233,273,283],"first-line":[19,73,332],"fluorouracil":[20,30,82,111,156,180,187,235,268],"+":[21,31,83,110,112,115,121,130,155,157,181,184,188,191,236,263,267,269],"folinic":[22,32,84,113,158,182,189,237,270],"acid":[23,33,85,183,190,238],"therapy":[24,34],"and":[25,204,308],"then":[26],"oxaliplatin":[27],"second-line":[29,254],"(or":[35],"the":[36,105,118,137,144,149,166,201,288],"reverse":[37],"sequence),":[38],"but":[39,136],"median":[40,219],"survival":[41,124,194,220],"time":[42,125,195,221],"still":[43],"fails":[44],"exceed":[46],"2":[47],"years.":[48],"(2)":[49],"Bevacizumab":[50,67,281],"a":[52,62,234,259,275],"monoclonal":[53],"antibody":[54],"directed":[55],"against":[56],"vascular":[57],"endothelial":[58],"growth":[59],"factor":[60],"(VEGF),":[61],"mediator":[63],"involved":[64],"in":[65,70,79,146,218],"angiogenesis.":[66],"marketed":[69],"Europe":[71],"of":[75,211,222,261,290,334],"cancer,":[78],"combination":[80],"with":[81,117,128,186],"(with":[86],"or":[87],"without":[88],"irinotecan).":[89],"(3)":[90],"clinical":[92],"evaluation":[93],"includes":[94],"3":[95,212],"comparative":[96,213],"trials.":[97],"A":[98,208],"double-blind":[99,171],"trial":[100,260],"involving":[101,173],"813":[102],"patients":[103],"compared":[104,176],"American":[106,178],"IFL":[107,119,129,167],"protocol":[108,120,151,161],"(irinotecan":[109,154],"acid)":[114,271],"placebo":[116,131],"bevacizumab.":[122,192,279],"Median":[123,193],"was":[126,231],"shorter":[127],"(15.6":[132],"versus":[133,226],"20.3":[134],"months),":[135],"difficult":[140],"extrapolate":[142],"situation":[145],"Europe,":[147],"where":[148],"FOLFIRI":[150],"used":[153],"acid).":[159],"This":[160],"more":[163],"effective":[164],"than":[165,249,326],"protocol.":[168],"(4)":[169],"Another":[170],"trial,":[172],"204":[174],"patients,":[175],"another":[177],"protocol,":[179],"placebo,":[185],"did":[196],"not":[197],"differ":[198],"significantly":[199],"between":[200],"groups":[202],"(12.9":[203],"16.6":[205],"months).":[206],"(5)":[207],"combined":[209],"analysis":[210],"trials":[214],"showed":[215],"an":[216],"increase":[217],"3.3":[223],"months":[224],"(17.9":[225],"14.6":[227],"months)":[228],"when":[229],"bevacizumab":[230,262,322],"added":[232],"combination.":[239],"An":[240],"indirect":[241],"comparison":[242],"suggests":[243],"that":[244,321],"this":[245],"no":[247,319],"better":[248,325],"irinotecan.":[251],"(6)":[252],"In":[253,315],"treatment,":[255],"preliminary":[256],"data":[257],"from":[258],"FOLFOX":[264],"4":[265],"(oxaliplatin":[266],"fail":[272],"show":[274],"tangible":[276],"benefit":[277],"(7)":[280],"adjunction":[282],"current":[284,327],"chemotherapy":[285,329],"protocols":[286,330],"increased":[287],"frequency":[289],"some":[291],"potentially":[292],"serious":[293],"reactions,":[294],"such":[295],"as":[296],"cardiovascular":[297],"disorders":[298,310],"(hypertension,":[299],"arterial":[300],"thrombosis);":[301],"tumour":[302],"haemorrhage;":[303],"intestinal":[304],"perforation;":[305],"wound":[306],"healing;":[307],"haematological":[309],"(severe":[311],"leukopenia,":[312],"etc.).":[313],"(8)":[314],"practice,":[316],"there":[317],"evidence":[320],"any":[324],"European":[328],"cancer.":[337]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4298029361","counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-10-01T00:00:00"}
